(800) 913-2022 | CONTACT PRODUCT FINDER

Search
Search
START TYPING AND PRESS ENTER TO SEARCH

News

Latest from Euroimmun US

About products, innovations and the company

Subject Category
Euroimmun US Blog

Jul 29, 2025 | News

Euroimmun Unveils New Visual Identity at ADLM 2025

Apr 02, 2025 | News

Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test

Sep 19, 2024 | News

Oropouche Virus Disease Among U.S. Travelers – United States, 2024

Apr 29, 2024 | News

The subsidiary ProciseDx announces distribution agreement with Revvity’s EUROIMMUN US for the distribution of the ProciseDx platform in the United State and Canada

Mar 22, 2023 | News

EUROIMMUN Wins 2023 New Jersey Top Workplaces Award

Jun 24, 2021 | News

SARS-CoV-2 Variants of Concern (VOC) Alpha, Beta, Gamma and Delta

Apr 17, 2020 | News

ABC News: Largest antibody study could answer crucial coronavirus questions

Nov 20, 2018 | News

Membranous Nephropathy: Antibody-based diagnosis, prognosis, and disease monitoring

Feb 27, 2018 | Video

Measles and Mumps Forgotten Diseases of Recurring Relevance

Jul 27, 2017 | Video

Autoimmune Encephalitis – Anti NMDAR and Beyond

Apr 12, 2017 | News

EUROIMMUN Announces Option Agreement with Roche on Zika Virus Serology

May 28, 2016 | News

EUROIMMUN CEO Interviewed by Clinical Lab Products in regard to Zika virus


Euroimmun US

Get in touch

1 Bloomfield Ave,
Mountain Lakes, NJ 07046

Phone: 800-913-2022
Fax: 973-656-1098
Email:

Quick Links

About

Products

IVD Status

News

Contact

Subscribe

Stay in the know about new product releases, events and more!

    Upon submission you consent to receive Euroimmun US email.

    2025 Euroimmun US

    Privacy Policy | Website Terms and Conditions | Cookie Notice and Settings | Consent Preferences | Sitemap